KLRK1 and Miyoshi myopathy: As regards to other activating NK receptors, a lower frequency of NKG2D+ and DNAM-1+ NK cells was observed in the context of MDS, AML, and MM (39, 52); moreover, NK cells from MM patients also displayed reduced levels of CD244, CD16, and CD161 (40, 41, 53, 54).